Literature DB >> 2430273

Anticholinergic-induced analgesia: possible role for the cholinergic system in abnormal sensory symptoms in Parkinson's disease.

R Sandyk.   

Abstract

Sensory symptoms related to pain perception have been reported to occur in 30-50% of parkinsonian patients. Two patients with Parkinson's disease are reported, in whom painful sensory phenomena preceded or accompanied the disease process. In both patients the sensory phenomena were unresponsive to therapy with oral narcotics, anti-inflammatory drugs or administration of levodopa/carbidopa. Benzhexol (4-6 mg/day) produced dramatic amelioration of symptoms, indicating a role for the cholinergic system in the pathophysiology of abnormal sensory symptoms in Parkinson's disease and possibly in human analgesia in general.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430273      PMCID: PMC2418816          DOI: 10.1136/pgmj.62.730.749

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  Primary sensory symptoms in parkinsonism.

Authors:  S R Snider; S Fahn; W P Isgreen; L J Cote
Journal:  Neurology       Date:  1976-05       Impact factor: 9.910

2.  Proceedings: The response of breast cancer patients with bone pain to L-dopa.

Authors:  J P Minton
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

3.  Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action.

Authors:  J T Coyle; S H Snyder
Journal:  Science       Date:  1969-11-14       Impact factor: 47.728

4.  Sensory symptoms: Parkinson's disease.

Authors:  R Sandyk; S R Snider
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

5.  Sensory symptoms in parkinsonism related to central dopaminergic function.

Authors:  J G Nutt; J H Carter
Journal:  Lancet       Date:  1984-08-25       Impact factor: 79.321

6.  Sensory symptoms in Parkinson's disease.

Authors:  W C Koller
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Monoaminergic mechanisms of stimulation-produced analgesia.

Authors:  H Akil; J C Liebeskind
Journal:  Brain Res       Date:  1975-08-29       Impact factor: 3.252

8.  Pain in Parkinson's disease.

Authors:  G D Schott
Journal:  Pain       Date:  1985-08       Impact factor: 6.961

9.  Anticholinesterase drugs in the treatment of chronic pain.

Authors:  G D Schott; L Loh
Journal:  Pain       Date:  1984-10       Impact factor: 6.961

10.  Administration of levodopa for relief of herpes zoster pain.

Authors:  S Kernbaum; J Hauchecorne
Journal:  JAMA       Date:  1981-07-10       Impact factor: 56.272

View more
  1 in total

Review 1.  Pineal melatonin and sensory symptoms in Parkinson disease.

Authors:  R Sandyk
Journal:  Ital J Neurol Sci       Date:  1989-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.